URIST MARSHALL (EVP & Co-Head Research & Inv.) received a stock award from ROYALTY PHARMA PLC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/13/2026ACC: 0001838139-26-000012
Officer· EVP & Co-Head Research & Inv.
Since Dec 2020
+19.97K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
19.97K acquired
Non-Derivative Transactions1
Class A Ordinary Shares
Direct
Shares
+19.97K
Price / share
—
Trade value
—
% of position
269.9%
2/11/2026
7.40K→27.37K
Total
Net shares
+19.97K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares Direct | 2/11/2026 | A · Award | +19.97K | — | — | 269.9% | 7.40K | 27.37K |
| Total | +19.97K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Ordinary Shares
IndirectShares owned19.02K
Total
19.02K indirect19.02K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Ordinary Shares | 19.02K | Indirect |
| Total | 19.02K | 19.02K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported